http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104327083-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d281e953d189bcfe2507ba7faba72c25
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
filingDate 2014-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_849fe541e19169543cfc5fdb696da380
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c45fbd8334e4d0030e3d48f21078aff4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bee13195d3ab16b4637245ec576d349
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7f71f550be0a73dc1bc86fb7cddd97b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efcf9ad3cff8bf50d09f1432207770f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_786cb460d9052b355f909635192173b2
publicationDate 2015-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104327083-A
titleOfInvention Substituted indane amide compounds and pharmaceutically acceptable salts thereof, preparation method and application thereof
abstract The present invention relates to a substituted dihydroindane amide compound represented by general formula I and a pharmaceutically acceptable salt thereof, a preparation method and application thereof. The present invention also provides their pharmaceutical composition, in vitro and in vivo anti-tumor effect research results and acute toxicity research results, the anti-tumor drug obtained in the present invention replaces dihydroindane amide compounds, and has better anti-tumor activity and safety Sex, especially anti-imatinib-resistant tumors, can be used in the treatment of leukemia, gastrointestinal stromal tumors, lung cancer, colon cancer, ovarian cancer and kidney cancer and other tumors, so the therapeutic window is wide, so in medicine It is very valuable as an anti-tumor agent in the field.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114656470-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10519105-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017183723-A1
priorityDate 2014-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102584830-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102775411-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012089106-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102295635-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014019338-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465045106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163519596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163430415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465097366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147494988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465832291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163768355
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68349612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID464970656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465453917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408514845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163482935

Total number of triples: 43.